118 related articles for article (PubMed ID: 12848649)
21. Distribution of human papillomavirus genotypes in women with cervical alterations from north Argentina.
Deluca GD; Marin HM; Blanco NS; Basiletti JA; González JV; Merino AL; Picconi MA
Indian J Med Microbiol; 2013; 31(2):138-41. PubMed ID: 23867669
[TBL] [Abstract][Full Text] [Related]
22. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
23. [Frequency of HPV infection of the uterine cervix among perimenopausal women in Wielkopolska Region].
Zietkowiak W; Zimna K; Sroka Ł; Uchman P; Sajdak S
Ginekol Pol; 2002 Nov; 73(11):939-44. PubMed ID: 12722378
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
25. Transitional cell metaplasia of the uterine cervix is related to human papillomavirus: molecular analysis in seven patients with cytohistologic correlation.
Ng WK; Cheung LK; Li AS; Cheung FM; Chow JC
Cancer; 2002 Aug; 96(4):250-8. PubMed ID: 12209668
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
27. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
28. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
29. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.
Andersson S; Rylander E; Larsson B; Strand A; Silfversvärd C; Wilander E
Eur J Cancer; 2001 Jan; 37(2):246-50. PubMed ID: 11166153
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association.
Chung TK; Cheung TH; Wang VW; Yu MY; Wong YF
Gynecol Obstet Invest; 2001; 52(2):98-103. PubMed ID: 11586036
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
[TBL] [Abstract][Full Text] [Related]
32. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
34. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection.
Andersson S; Larson B; Hjerpe A; Silfverswärd C; Sällström J; Wilander E; Rylander E
Acta Obstet Gynecol Scand; 2003 Oct; 82(10):960-5. PubMed ID: 12956848
[TBL] [Abstract][Full Text] [Related]
36. Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction.
Chang DY; Hsieh CY; Chen RJ; Lee SC; Huang SC
J Med Microbiol; 1995 Dec; 43(6):430-5. PubMed ID: 7473676
[TBL] [Abstract][Full Text] [Related]
37. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
38. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus infection and invasive cervical cancer in Paraguay.
Rolón PA; Smith JS; Muñoz N; Klug SJ; Herrero R; Bosch X; Llamosas F; Meijer CJ; Walboomers JM
Int J Cancer; 2000 Feb; 85(4):486-91. PubMed ID: 10699919
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso.
Djigma FW; Ouédraogo C; Karou DS; Sagna T; Bisseye C; Zeba M; Ouermi D; Gnoula C; Pietra V; Ghilat-Avoid-Belem NW; Sanogo K; Sempore J; Pignatelli S; Ferri AM; Nikiema JB; Simpore J
Acta Trop; 2011 Mar; 117(3):202-6. PubMed ID: 21167118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
